Tomas Rozek

680 total citations
15 papers, 570 citations indexed

About

Tomas Rozek is a scholar working on Organic Chemistry, Molecular Biology and Microbiology. According to data from OpenAlex, Tomas Rozek has authored 15 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Microbiology. Recurrent topics in Tomas Rozek's work include Carbohydrate Chemistry and Synthesis (5 papers), Antimicrobial Peptides and Activities (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Tomas Rozek is often cited by papers focused on Carbohydrate Chemistry and Synthesis (5 papers), Antimicrobial Peptides and Activities (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Tomas Rozek collaborates with scholars based in Australia, France and United Kingdom. Tomas Rozek's co-authors include John H. Bowie, John C. Wallace, Michael J. Tyler, Kate L. Wegener, Ian Olver, John A. Carver, Maria Fuller, John J. Hopwood, Simon T. Steinborner and Russell J. Waugh and has published in prestigious journals such as Analytical Biochemistry, European Journal of Biochemistry and European Journal of Neuroscience.

In The Last Decade

Tomas Rozek

15 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Rozek Australia 8 353 352 87 79 75 15 570
Stephanie Chaousis Australia 15 199 0.6× 560 1.6× 84 1.0× 77 1.0× 21 0.3× 18 707
Linda Poulter United Kingdom 16 390 1.1× 758 2.2× 174 2.0× 55 0.7× 31 0.4× 19 1.0k
Ajay K. Mahalka Finland 9 100 0.3× 495 1.4× 63 0.7× 49 0.6× 173 2.3× 12 746
Shigeyuki Terada Japan 13 34 0.1× 334 0.9× 30 0.3× 29 0.4× 36 0.5× 56 509
F. Ducancel France 12 103 0.3× 486 1.4× 84 1.0× 11 0.1× 21 0.3× 18 653
Keith K. Khoo Australia 13 47 0.1× 471 1.3× 41 0.5× 35 0.4× 18 0.2× 15 651
Bethany A. Buck‐Koehntop United States 15 135 0.4× 558 1.6× 51 0.6× 72 0.9× 19 0.3× 23 718
Hiroaki Kawauchi Japan 17 38 0.1× 498 1.4× 329 3.8× 25 0.3× 46 0.6× 41 668
Laura Biondi Italy 13 75 0.2× 326 0.9× 38 0.4× 165 2.1× 11 0.1× 57 458
Leonid M. Vinokurov Russia 14 82 0.2× 581 1.7× 62 0.7× 29 0.4× 27 0.4× 24 746

Countries citing papers authored by Tomas Rozek

Since Specialization
Citations

This map shows the geographic impact of Tomas Rozek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Rozek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Rozek more than expected).

Fields of papers citing papers by Tomas Rozek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Rozek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Rozek. The network helps show where Tomas Rozek may publish in the future.

Co-authorship network of co-authors of Tomas Rozek

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Rozek. A scholar is included among the top collaborators of Tomas Rozek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Rozek. Tomas Rozek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rozek, Tomas, et al.. (2025). Prostanoids as markers of oxidative stress in stallion semen. Journal of Equine Veterinary Science. 145. 105287–105287. 1 indexed citations
2.
Rozek, Tomas, et al.. (2024). The Multi-Omic Approach to Newborn Screening: Opportunities and Challenges. International Journal of Neonatal Screening. 10(3). 42–42. 6 indexed citations
3.
Rozek, Tomas, et al.. (2020). Stability of a compounded oral liquid formulation of clopidogrel for infants. Journal of Pharmacy Practice and Research. 50(4). 321–328. 2 indexed citations
4.
Rozek, Tomas, Ashley M. Hopkins, Susanna Proudman, et al.. (2011). Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 55(2). 325–331. 41 indexed citations
5.
Nielsen, Timothy C., Tomas Rozek, John J. Hopwood, & Maria Fuller. (2010). Determination of urinary oligosaccharides by high-performance liquid chromatography/electrospray ionization–tandem mass spectrometry: Application to Hunter syndrome. Analytical Biochemistry. 402(2). 113–120. 30 indexed citations
6.
Hemsley, Kim M., Amanda Luck, Allison C. Crawley, et al.. (2009). Examination of intravenous and intra‐CSF protein delivery for treatment of neurological disease. European Journal of Neuroscience. 29(6). 1197–1214. 58 indexed citations
7.
Doyle, Jason, Lyndon Llewellyn, Craig S. Brinkworth, et al.. (2002). Amphibian peptides that inhibit neuronal nitric oxide synthase. European Journal of Biochemistry. 269(1). 100–109. 45 indexed citations
8.
Rozek, Tomas, John H. Bowie, Simon M. Pyke, Brian W. Skelton, & Allan H. White. (2001). A regio- and stereo-selective synthesis of 2-hydroxy-3-methylochromycinone in three steps from 2-bromo-5-acetoxy-1,4-naphthoquinone and 1-acetoxy-3,3-dimethyl-5-vinylcyclohexa-1,5-diene†. Journal of the Chemical Society Perkin Transactions 1. 1826–1830. 9 indexed citations
9.
Rozek, Tomas, Kate L. Wegener, John H. Bowie, et al.. (2000). The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis. European Journal of Biochemistry. 267(17). 5330–5341. 244 indexed citations
10.
Rozek, Tomas, John H. Bowie, John C. Wallace, & Michael J. Tyler. (2000). The antibiotic and anticancer active aurein peptides from the Australian Bell FrogsLitoria aurea andLitoria raniformis. Part 2. Sequence determination using electrospray mass spectrometry. Rapid Communications in Mass Spectrometry. 14(21). 2002–2011. 53 indexed citations
11.
Brinkworth, Craig S., Tomas Rozek, John H. Bowie, Brian W. Skelton, & Allan H. White. (2000). Angucyclinones Related to Ochromycinone. IV. The Structures and Reactions of Unusual Diels-Alder Adducts Formed from Maleic Anhydride and Racemic 5,5-Dimethyl-3-vinylcyclohex-2-en-1-ol. Australian Journal of Chemistry. 53(5). 403–409. 2 indexed citations
12.
Rozek, Tomas, Dennis K. Taylor, Edward R. T. Tiekink, & John H. Bowie. (1999). Syntheses of Angucyclinones Related to Ochromycinone. III. An 11-Hydroxy Isomer and Some Reduced Analogues. Australian Journal of Chemistry. 52(2). 129–136. 2 indexed citations
13.
Rozek, Tomas, Russell J. Waugh, Simon T. Steinborner, et al.. (1998). The Maculatin peptides from the skin glands of the tree frogLitoria genimaculata: a comparison of the structures and antibacterial activities of Maculatin 1.1 and Caerin 1.1. Journal of Peptide Science. 4(2). 111–115. 69 indexed citations
14.
Rozek, Tomas, John M. Hevko, Edward R. T. Tiekink, et al.. (1998). Syntheses of Angucyclinones Related to Ochromycinone. Australian Journal of Chemistry. 51(6). 515–524. 6 indexed citations
15.
Rozek, Tomas, Edward R. T. Tiekink, Dennis K. Taylor, & John H. Bowie. (1998). Syntheses of Angucyclinones Related to Ochromycinone. II. Regio- and Stereo-selective Reduction of a Tetrahydroangucyclinone. Australian Journal of Chemistry. 51(11). 1057–1060. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026